Status:
COMPLETED
Montelukast in Bronchiolitis Obliterans Syndrome
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
KU Leuven
Conditions:
Bronchiolitis Obliterans
Lung Transplantation
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Chronic rejection (or Bronchiolitis Obliterans syndrome-BOS) is a major cause of mortality and morbidity after lung transplantation. Because montelukast has been shown to be of some efficacy in a simi...
Detailed Description
* Prospective, interventional, randomized, double-blind, placebo-controlled trial. * Clinical setting (tertiary University Hospital). * Investigator-driven, no pharmaceutical sponsor. * Lung transplan...
Eligibility Criteria
Inclusion
- Diagnosis of fBOS
- Signed informed consent
- Age at least 18 years old at moment of transplantation
- Able to take oral medication
Exclusion
- Retransplantation
- Previous organ transplantation
- Multi organ transplantation
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01211509
Start Date
October 1 2010
End Date
March 1 2015
Last Update
March 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Gasthuisberg
Leuven, Belgium, 3000